Jeff Yass’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-57,400
| Closed | -$178K | – | 14668 |
|
|
2021
Q4 | $178K | Sell |
57,400
-28,200
| -33% | -$94.9K | ﹤0.01% | 11587 |
|
|
2021
Q3 | $309K | Buy |
85,600
+3,000
| +4% | +$11.3K | ﹤0.01% | 10539 |
|
|
2021
Q2 | $296K | Buy |
82,600
+59,700
| +261% | +$211K | ﹤0.01% | 10799 |
|
|
2021
Q1 | $90K | Buy |
+22,900
| New | +$94.6K | ﹤0.01% | 11897 |
|
|
2020
Q4 | – | Sell |
-86,100
| Closed | -$321K | – | 12179 |
|
|
2020
Q3 | $321K | Buy |
86,100
+74,300
| +630% | +$316K | ﹤0.01% | 8565 |
|
|
2020
Q2 | $51K | Sell |
11,800
-2,900
| -20% | -$13K | ﹤0.01% | 9750 |
|
|
2020
Q1 | $56K | Sell |
14,700
-22,600
| -61% | -$111K | ﹤0.01% | 9637 |
|
|
2019
Q4 | $236K | Sell |
37,300
-44,000
| -54% | -$259K | ﹤0.01% | 8469 |
|
|
2019
Q3 | $342K | Sell |
81,300
-32,700
| -29% | -$140K | ﹤0.01% | 8022 |
|
|
2019
Q2 | $530K | Sell |
114,000
-24,200
| -18% | -$113K | ﹤0.01% | 7142 |
|
|
2019
Q1 | $732K | Buy |
138,200
+104,100
| +305% | +$475K | ﹤0.01% | 5601 |
|
|
2018
Q4 | $126K | Sell |
34,100
-300
| -0.9% | -$1.05K | ﹤0.01% | 8100 |
|
|
2018
Q3 | $96K | Sell |
34,400
-15,000
| -30% | -$42.1K | ﹤0.01% | 8624 |
|
|
2018
Q2 | $146K | Buy |
49,400
+20,400
| +70% | +$48.4K | ﹤0.01% | 8860 |
|
|
2018
Q1 | $65K | Sell |
29,000
-38,300
| -57% | -$89.6K | ﹤0.01% | 8872 |
|
|
2017
Q4 | $199K | Sell |
67,300
-12,400
| -16% | -$34.3K | ﹤0.01% | 8288 |
|
|
2017
Q3 | $235K | Sell |
79,700
-12,200
| -13% | -$37.2K | ﹤0.01% | 7776 |
|
|
2017
Q2 | $257K | Buy |
91,900
+45,500
| +98% | +$96K | ﹤0.01% | 7851 |
|
|
2017
Q1 | $88K | Sell |
46,400
-73,200
| -61% | -$141K | ﹤0.01% | 8441 |
|
|
2016
Q4 | $209K | Buy |
119,600
+30,900
| +35% | +$63.1K | ﹤0.01% | 8596 |
|
|
2016
Q3 | $239K | Buy |
88,700
+38,100
| +75% | +$96.8K | ﹤0.01% | 7308 |
|
|
2016
Q2 | $119K | Sell |
50,600
-35,200
| -41% | -$97.1K | ﹤0.01% | 7945 |
|
|
2016
Q1 | $277K | Sell |
85,800
-67,300
| -44% | -$249K | ﹤0.01% | 7397 |
|
|
2015
Q4 | $733K | Sell |
153,100
-558,200
| -78% | -$3.16M | ﹤0.01% | 6042 |
|
|
2015
Q3 | $3.96M | Buy |
711,300
+28,800
| +4% | +$213K | ﹤0.01% | 3022 |
|
|
2015
Q2 | $5.43M | Buy |
682,500
+470,600
| +222% | +$4.04M | ﹤0.01% | 2786 |
|
|
2015
Q1 | $2.23M | Buy |
211,900
+55,000
| +35% | +$751K | ﹤0.01% | 4124 |
|
|
2014
Q4 | $1.89M | Sell |
156,900
-3,900
| -2% | -$59.3K | ﹤0.01% | 4564 |
|
|
2014
Q3 | $2.75M | Sell |
160,800
-410,800
| -72% | -$5.96M | ﹤0.01% | 4055 |
|
|
2014
Q2 | $6.9M | Buy |
571,600
+561,600
| +5,616% | +$5.32M | ﹤0.01% | 2594 |
|
|
2014
Q1 | $84K | Buy |
+10,000
| New | +$80.7K | ﹤0.01% | 8616 |
|
|
2013
Q3 | – | Sell |
-10,800
| Closed | -$44K | – | 9244 |
|
|
2013
Q2 | $44K | Buy |
+10,800
| New | +$50.7K | ﹤0.01% | 8006 |
|
Other funds holding BDSI
Jeff Yass's BDSI Position: Q1 2022 in Review
Jeff Yass sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 323,783 shares — an estimated $1M sold.
Jeff Yass first reported a position in BDSI in Q3 2013 and held it in 32 quarters. The position peaked at $4.57M in Q3 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Jeff Yass reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Jeff Yass sold 323,783 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1M.
- Jeff Yass first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 32 quarters.
- Jeff Yass's BioDelivery Sciences International, Inc. position peaked at $4.57M in Q3 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.